News

Nafsika Karavida Discusses U.S. and EU Approaches to Vaccine Patents and Compulsory Licensing Amid COVID-19

Governments, pharmaceutical companies and medical researchers around the world are racing to produce a vaccine for COVID-19, as well as potential drugs to fight the virus in those who contract it. The numbers show at least 70 reported potential vaccines and 150 other drugs for treatment that are in development...

Read More

Considerations for Employers When Contemplating Employee Furloughs or Reductions in Force in the COVID-19 Environment

Many employers are rightfully concerned with how best to manage the business and financial impact and implications of the COVID-19 outbreak and resulting closures and dislocations. Some are considering temporary furloughs of workers as an alternative to terminations or reductions in force (“RIFs”). Below, we provide a general overview of these employer...

Read More